Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a weekly shot tame blood sugar in type 2 diabetes?

NCT ID NCT07754461

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Sep 18, 2026 · Updated 6 times

Summary

This phase 3 trial asks whether survodutide, an investigational weekly injection, can help adults with type 2 diabetes lower their blood sugar more than a placebo. Around 600 participants, who also follow diet and exercise or take standard diabetes medications (including insulin), will be randomly assigned to one of two survodutide doses or placebo for about a year. The study tracks changes in HbA1c, a key blood sugar marker, to see if the treatment is effective and safe.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
survodutide (BI 456906), an investigational injectable medicine
What this could lead to
If it works, survodutide could offer a new weekly injection option to help people with type 2 diabetes better control their blood sugar.
What could go wrong
This is an early-phase test in a large group; survodutide may not prove more effective than placebo, and side effects are possible. Results will take time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. Male or female, age ≥18 years at the time of signing informed consent, and at least the legal age of consent in countries where it is \>18 years 2. Diagnosed with type 2 diabetes mellitus (T2D) (e.g. American diabetes association (ADA)/European association for the study of diabetes (EASD) guidelines) and must meet requirements for one of background therapy parts A, B or C: 1. Part A: Naïve to insulin therapy and have not used oral or injectable anti-hyperglycaemic (diabetes) medication for at least 90 days prior to screening (Visit 1) and glycosylated haemoglobin A1c (HbA1c) ≥7.0 (≥53 mmol/mol) and \<9.5% (\<80 mmol/mol) as measured by the central laboratory at screening (Visit 1); 2. Part B: Treated with stable dose of oral antidiabetic medication (OAD) for 90 days prior to screening (Visit 1) as monotherapy or combination of: Maximum tolerated dose of metformin and/or Maximum tolerated dose of sulfonylurea and/or Maximum tolerated dose of sodium-glucose cotransporter 2 inhibitor (SGLT2i) and HbA1c ≥7.0% (≥53 mmol/mol) and \<10.5% (\<91 mmol/mol) as measured by the central laboratory at screening (Visit 1); 3. Part C: Stable use of basal insulin at a dose of ≥20 international units (IU)/day with or without stable dose of metformin and/or SGLT2i for 90 days prior to screening (Visit 1) and HbA1c ≥7.0% (≥53 mmol/mol) and \<10.5% (\<91 mmol/mol) as measured by the central laboratory at screening (Visit 1) 3. Body mass index (BMI) ≥23 kg/m2 at screening (Visit 1) 4. Signed and dated written informed consent in accordance with international council for harmonisation - good clinical practice (ICH-GCP) and local legislation prior to admission to the trial 5. Woman (or women) of childbearing potential (WOCBP) must be ready and able to use highly effective methods of birth control per international council for harmonisation of technical requirements for pharmaceuticals for human use M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly. 6. In the investigator's opinion, participants are well-motivated, capable, and willing to: Learn how to self-inject the investigational medicinal product (IMP), as required for this protocol (persons with physical limitations who are not able to perform the injections must have the assistance of an individual trained to inject the IMP); Inject the IMP or accept injection from a designated person; Follow study procedures for the duration of the study, including, but not limited to: follow lifestyle advice (for example, dietary restrictions and exercise plan), maintain a diary, complete required questionnaires, and handle the IMP as described in the instructions for use (IFU) Exclusion criteria: 1. Type 1 diabetes mellitus (T1D) or latent autoimmune diabetes in adults (LADA) 2. Treatment within 90 days before screening (Visit 1) up to and including randomisation (Visit 2) with any: glucagon-like peptide-1 receptor (GLP-1R) agonists including GLP-1R agonist/glucose-dependent insulinotropic polypeptide (GIP) combinations, amylin or incretin combinations; Glucose-lowering drugs other than stated in the inclusion criteria for each part (i.e. metformin, Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i), basal insulin, depending on the background therapy part); Glucose-lowering investigational drug; Any anti-obesity medication including bupropion/naltrexone, orlistat, phentermine, and phentermine/topiramate 3. History of ketoacidosis or hyperosmolar state or coma within the last 6 months before screening (Visit 1) up to and including randomisation (Visit 2) 4. Hypoglycaemia unawareness or a history of severe hypoglycaemia within the last 3 months before screening (Visit 1) up to and including randomisation (Visit 2) 5. Diabetic retinopathy or maculopathy currently under treatment, or that is reasonably anticipated to require such treatment over the duration of the study 6. Body weight change (self-reported) \>5% within 90 days before screening (Visit 1) 7. Previous or planned (during the trial period) treatment for obesity with surgery or a weight loss device, including any prior bariatric surgery. The following are allowed: (1) liposuction and/or abdominoplasty, if performed \>1 year before screening (Visit 1), (2) lap banding, if the band has been removed \>1 year before screening (Visit 1), (3) intragastric balloon, if the balloon has been removed \>1 year before screening (Visit 1), (4) duodenal-jejunal bypass sleeve, if the sleeve has been removed \>1 year before screening (Visit 1). 8. Answered "yes" to any of the suicide-related behaviours (Actual attempt, Interrupted attempt, Aborted attempt, Preparatory act or behaviour) or to the non-suicidal self-injurious behaviour question on the "Suicidal Behaviour" section of the Columbia-Suicide Severity Rating Scale (C-SSRS) related to the past 2 years before screening (Visit 1) up to and including randomisation (Visit 2) 9. Further exclusion criteria apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    121 sites in 6 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AIIMS Bhubaneshwar

    NOT_YET_RECRUITING

    Bhubaneswar, 751019, India

  • AIIMS, New Delhi

    NOT_YET_RECRUITING

    New Delhi, 110029, India

  • AMR Lexington

    NOT_YET_RECRUITING

    Lexington, Kentucky, 40509, United States

  • ARK Clinical Research

    RECRUITING

    Long Beach, California, 90815, United States

  • Accel Research Sites - Lakeland

    NOT_YET_RECRUITING

    Lakeland, Florida, 33803, United States

  • Advanced Medical Research - Maumee

    NOT_YET_RECRUITING

    Maumee, Ohio, 43537, United States

  • Albion Finch Medical Centre

    NOT_YET_RECRUITING

    Toronto, Ontario, M9V 4B4, Canada

  • Albuquerque Clinical Trials

    NOT_YET_RECRUITING

    Albuquerque, New Mexico, 87102, United States

  • Applied Medical Informatics Research Inc.

    NOT_YET_RECRUITING

    Montreal, Quebec, H4A 3T2, Canada

  • Arcturus Healthcare - Troy Internal Medicine Research Division

    NOT_YET_RECRUITING

    Troy, Michigan, 48098, United States

  • Arizona Liver Health - Peoria 85381

    NOT_YET_RECRUITING

    Peoria, Arizona, 85381, United States

  • Baker Heart and Diabetes Institute

    NOT_YET_RECRUITING

    Melbourne, Victoria, 3004, Australia

  • Balanced Life Health Care Solutions

    NOT_YET_RECRUITING

    Lawrenceville, Georgia, 30046, United States

  • Biopharma Informatic, Inc. Research Center

    NOT_YET_RECRUITING

    Houston, Texas, 77084, United States

  • Boeson Research - Missoula

    NOT_YET_RECRUITING

    Missoula, Montana, 59804, United States

  • Cahaba Research, Inc. - Trussville Location

    NOT_YET_RECRUITING

    Birmingham, Alabama, 35235, United States

  • Centricity Research (Bayview)

    NOT_YET_RECRUITING

    Toronto, Ontario, M4G 3E8, Canada

  • Centricity Research (Brampton)

    RECRUITING

    Brampton, Ontario, L6S 0C6, Canada

  • Centricity Research (Nepean)

    NOT_YET_RECRUITING

    Nepean, Ontario, K2J 0V2, Canada

  • Centricity Research (Vaughan)

    NOT_YET_RECRUITING

    Concord, Ontario, L4K 4M2, Canada

  • Centricity Research - Morehead City

    RECRUITING

    Morehead City, North Carolina, 28557, United States

  • Centricity Research, Endocrine Consultants

    RECRUITING

    Columbus, Georgia, 31904, United States

  • Clinical Investigation Specialists, Inc.-Kenosha-69111

    NOT_YET_RECRUITING

    Kenosha, Wisconsin, 53144, United States

  • Clinical Research of Central Florida - Lakeland

    NOT_YET_RECRUITING

    Lakeland, Florida, 33805, United States

  • Clinical Research of West Florida, Inc.

    RECRUITING

    Clearwater, Florida, 33765, United States

  • Clinical Trials New Zealand Ltd

    NOT_YET_RECRUITING

    Hamilton, 3204, New Zealand

  • Clinical Trials Research - Lincoln

    NOT_YET_RECRUITING

    Lincoln, California, 95648, United States

  • Conquest Research

    RECRUITING

    Winter Park, Florida, 32789, United States

  • Consano Clinical Research

    NOT_YET_RECRUITING

    Shavano Park, Texas, 78231, United States

  • Cotton O'Neil Mulvane

    NOT_YET_RECRUITING

    Topeka, Kansas, 66606, United States

  • Covenant Metabolic Specialists, LLC - Brandon

    RECRUITING

    Riverview, Florida, 33578, United States

  • Covenant Metabolic Specialists, LLC - Fort Myers

    RECRUITING

    Fort Myers, Florida, 33912, United States

  • Covenant Metabolic Specialists, LLC - Sarasota

    RECRUITING

    University Park, Florida, 34201, United States

  • Deenanath Mangeshkar Hospital and Research Centre

    NOT_YET_RECRUITING

    Pune, 411004, India

  • Diabetes & Endocrinology Associates of Stark County

    NOT_YET_RECRUITING

    Canton, Ohio, 44718, United States

  • Diabetes Care and Research Centre

    NOT_YET_RECRUITING

    Nagpur, 440010, India

  • Diabetes Heart Research Centre

    NOT_YET_RECRUITING

    Toronto, Ontario, M6G 1M2, Canada

  • Diablo Clinical Research

    RECRUITING

    Walnut Creek, California, 94598, United States

  • ERA Health Research - Redmond

    RECRUITING

    Redmond, Washington, 98052, United States

  • Elite Clinical Trials - Blackfoot

    NOT_YET_RECRUITING

    Blackfoot, Idaho, 83221, United States

  • Ellipsis Research Group - Brooklyn

    NOT_YET_RECRUITING

    Brooklyn, New York, 11215, United States

  • Encompass Clinical Research, Spring Valley

    RECRUITING

    Spring Valley, California, 91978, United States

  • Encore Medical Research

    RECRUITING

    Hollywood, Florida, 33024, United States

  • Encore Medical Research - Weston

    RECRUITING

    Weston, Florida, 33331, United States

  • Endocrine and Metabolic Consultants

    NOT_YET_RECRUITING

    Rockville, Maryland, 20852, United States

  • Endocrinologie Oasis Inc

    RECRUITING

    Montreal, Quebec, H4J 1E3, Canada

  • Evanston Premier Healthcare Research LLC

    NOT_YET_RECRUITING

    Skokie, Illinois, 60077, United States

  • Family First Clinical Research

    NOT_YET_RECRUITING

    Idaho Falls, Idaho, 83404, United States

  • Focus Clinical Research

    RECRUITING

    West Hills, California, 91307, United States

  • Fomat Medical Research

    NOT_YET_RECRUITING

    Oxnard, California, 93030, United States

  • Fraser Clinical Trials

    RECRUITING

    New Westminster, British Columbia, V3L 3W4, Canada

  • Gujarat Endocrine Centre

    NOT_YET_RECRUITING

    Ahmedabad, 380006, India

  • Helios Clinical Research - Paradise Valley

    NOT_YET_RECRUITING

    Paradise Valley, Arizona, 85253, United States

  • Helios Clinical Research - Phoenix

    NOT_YET_RECRUITING

    Phoenix, Arizona, 85028, United States

  • Heritage Valley Medical Group

    NOT_YET_RECRUITING

    Beaver, Pennsylvania, 15009, United States

  • Infinity Clinical Research

    NOT_YET_RECRUITING

    Norco, California, 92860, United States

  • International Diabetes Center

    NOT_YET_RECRUITING

    Minneapolis, Minnesota, 55416, United States

  • Isis Clinical Research Center

    NOT_YET_RECRUITING

    Guaynabo, 00968, Puerto Rico

  • Javara Inc. - Cape Fear Valley Medical Center

    NOT_YET_RECRUITING

    Fayetteville, North Carolina, 28304, United States

  • Javara-Fayetteville-67354

    RECRUITING

    Fayetteville, Georgia, 30214, United States

  • John Muir Physician Network Clinical Research Center

    RECRUITING

    Concord, California, 94520, United States

  • Jothydev's Diabetes Research Centre

    NOT_YET_RECRUITING

    Trivandrum, 695032, India

  • Juno Research, LLC

    NOT_YET_RECRUITING

    Houston, Texas, 77040, United States

  • LifeDoc Research, PLLC

    NOT_YET_RECRUITING

    Memphis, Tennessee, 38115, United States

  • Logan Health Research - Kalispell

    NOT_YET_RECRUITING

    Kalispell, Montana, 59901, United States

  • Logan Hospital

    NOT_YET_RECRUITING

    Meadowbrook, Queensland, 4131, Australia

  • Metabolic Research Institute, Inc.

    NOT_YET_RECRUITING

    West Palm Beach, Florida, 33401, United States

  • Mission Research Institute - Gilbert

    NOT_YET_RECRUITING

    Gilbert, Arizona, 85296, United States

  • Momentum Clinical Research Dunedin

    NOT_YET_RECRUITING

    Central Dunedin, Dunedin, 9016, New Zealand

  • Neighborhood Healthcare - Escondido

    NOT_YET_RECRUITING

    Escondido, California, 92025, United States

  • New Horizon Research Center-Miami-69732

    NOT_YET_RECRUITING

    Miami, Florida, 33165, United States

  • New Venture Medical Research

    NOT_YET_RECRUITING

    Wadsworth, Ohio, 44281, United States

  • New Zealand Clinical Research (NZCR) Christchurch

    NOT_YET_RECRUITING

    Christchurch Central City, Christchurch, 8011, New Zealand

  • Northeast Research Institute

    NOT_YET_RECRUITING

    Fleming Island, Florida, 32003, United States

  • Northeast Research Institute

    NOT_YET_RECRUITING

    Jacksonville, Florida, 32204, United States

  • Northern Pines Health Center - Buckley

    NOT_YET_RECRUITING

    Buckley, Michigan, 49620, United States

  • Olive Branch Family Medical Center

    NOT_YET_RECRUITING

    Olive Branch, Mississippi, 38654, United States

  • Olympus Family Medicine

    RECRUITING

    Salt Lake City, Utah, 84117, United States

  • Osmania Medical College & Hospital

    NOT_YET_RECRUITING

    Hyderabad, Afzalgunj, 500012, India

  • Pacific Diabetes & Endocrine Center

    NOT_YET_RECRUITING

    Honolulu, Hawaii, 96817, United States

  • Palm Research Center

    NOT_YET_RECRUITING

    Las Vegas, Nevada, 89128, United States

  • PanAmerican Clinical Research - Bluffton

    NOT_YET_RECRUITING

    Bluffton, South Carolina, 29910, United States

  • PharmQuest Life Sciences

    NOT_YET_RECRUITING

    Greensboro, North Carolina, 27408, United States

  • Pinnacle Clinical Research - Georgetown

    RECRUITING

    Georgetown, Texas, 78626, United States

  • Pinnacle Clinical Research - San Antonio

    RECRUITING

    San Antonio, Texas, 78222, United States

  • Pinnacle Clinical Research, LLC

    NOT_YET_RECRUITING

    San Antonio, Texas, 78229, United States

  • Preferred Primary Care Physicians

    NOT_YET_RECRUITING

    Pittsburgh, Pennsylvania, 15243, United States

  • Preferred Primary Care Physicians - Matthew Drive

    NOT_YET_RECRUITING

    Uniontown, Pennsylvania, 15401, United States

  • Preferred Primary Care Physicians-Pittsburgh-63932

    NOT_YET_RECRUITING

    Pittsburgh, Pennsylvania, 15236, United States

  • Privia Medical Group Gulf Coast, PLLC

    RECRUITING

    Conroe, Texas, 77384, United States

  • Recherche Clinique Sigma Inc.

    RECRUITING

    Québec, G1G 5X1, Canada

  • Research Physicians Network

    NOT_YET_RECRUITING

    Houston, Texas, 77089, United States

  • Revival Research Institute, LLC - Dearborn

    RECRUITING

    Dearborn, Michigan, 48126, United States

  • Rophe Adult and Pediatric Medicine

    NOT_YET_RECRUITING

    Union City, Georgia, 30291, United States

  • Royal Prince Alfred Hospital

    NOT_YET_RECRUITING

    Camperdown, New South Wales, 2050, Australia

  • S.C.B. Medical College & Hospital

    NOT_YET_RECRUITING

    Cuttack, 753007, India

  • SKY Clinical Research Network Group - Ridgeland

    NOT_YET_RECRUITING

    Ridgeland, Mississippi, 39157, United States

  • San Fernando Valley Health

    NOT_YET_RECRUITING

    Canoga Park, California, 91304, United States

  • Sanjay Gandhi Post Graduate Institute of Medical Sciences

    NOT_YET_RECRUITING

    Lucknow, 226 014, India

  • Sardar Vallabhbhai Patel Institute of Medical Sciences and Research

    NOT_YET_RECRUITING

    Ahmedabad, 380006, India

  • Shree Mahalaxmi Diatone Institute

    NOT_YET_RECRUITING

    Kolhāpur, 416003, India

  • Solaris Clinical Research

    NOT_YET_RECRUITING

    Meridian, Idaho, 83646, United States

  • South Broward Research

    NOT_YET_RECRUITING

    Miramar, Florida, 33027, United States

  • South Texas Research Institute - Brownsville

    NOT_YET_RECRUITING

    Brownsville, Texas, 78520, United States

  • Southern Adelaide Diabetes & Endocrine services

    NOT_YET_RECRUITING

    Oaklands Park, South Australia, 5046, Australia

  • Southern Endocrinology Associates

    NOT_YET_RECRUITING

    Mesquite, Texas, 75149, United States

  • Spartanburg Medical Research

    NOT_YET_RECRUITING

    Spartanburg, South Carolina, 29303, United States

  • StudyMetrix Research, LLC

    NOT_YET_RECRUITING

    City of Saint Peters, Missouri, 63303, United States

  • Supe Heart & Diabetes Hospital & Research Centre

    NOT_YET_RECRUITING

    Nashik, 422002, India

  • Tampa Bay Medical Research - Largo

    RECRUITING

    Largo, Florida, 33777, United States

  • Tekton Research Oklahoma City

    RECRUITING

    Oklahoma City, Oklahoma, 73134, United States

  • Texas Diabetes and Endocrinology - Central Austin

    RECRUITING

    Austin, Texas, 78731, United States

  • Texas Valley Clinical Research

    NOT_YET_RECRUITING

    Weslaco, Texas, 78596, United States

  • Tidewater Physicians Multispecialty Group

    NOT_YET_RECRUITING

    Newport News, Virginia, 23606, United States

  • University Clinical Investigators, Inc.

    NOT_YET_RECRUITING

    Tustin, California, 92780, United States

  • University Diabetes & Endocrine Consultants

    RECRUITING

    Chattanooga, Tennessee, 37411, United States

  • University of Texas Southwestern Medical Center

    NOT_YET_RECRUITING

    Dallas, Texas, 75390-8837, United States

  • Valley Clinical Trials, Inc.

    RECRUITING

    Northridge, California, 91325, United States

  • Vishakha Institute of Medical Sciences

    NOT_YET_RECRUITING

    Visakhapatnam, 530040, India

  • Waitemata Clinical Research

    NOT_YET_RECRUITING

    Auckland, 0626, New Zealand

  • Woodland International Research Group, Inc.

    RECRUITING

    Little Rock, Arkansas, 72211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.